BridgeMD
New treatment option for Parkinson Disease
Official title Remote Mental Practice for Freezing of Gait in Parkinson's Disease
ClinicalTrials.gov ID: NCT06957405
What this study is testing
- What it's testing
- This single-blind, randomized controlled trial investigates the effects of a remotely delivered intervention based on mental practice (MP) combined with physical practice (PP) on freezing of gait (FOG) severity in people with idiopathic Parkinson's disease (PD). Fifty participants will be randomly assigned to either the experimental group (MP + PP) or a control group (PP + stretching).
- Time commitment: about 6 weeks
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Adults
You may be able to join if
- Clinical diagnosis of idiopathic PD;
- Use of dopaminergic medication;
- Experiencing FOG (positive response to the first question of the New Freezing of Gait Questionnaire - NFOG-Q);
- Able to walk independently at home;
- Access to internet and video call device;
You likely can't join if
- Other neurological disorders;
- Severe cardiovascular and/or respiratory alterations;
- Uncorrected visual and/or auditory alterations;
- Cognitive impairment, detectable through the Telephone Montreal Cognitive Assessment (T-MoCA, \< 12);
- Inability to perform motor imageryT during the administration of the Kinesthetic and Visual Imagery Questionnaire - 20 (KVIQ-20, \< 20)
See the full eligibility criteria
- Clinical diagnosis of idiopathic PD;
- Use of dopaminergic medication;
- Experiencing FOG (positive response to the first question of the New Freezing of Gait Questionnaire - NFOG-Q);
- Able to walk independently at home;
- Access to internet and video call device;
- Agree to participate in the study.
- Other neurological disorders;
- Severe cardiovascular and/or respiratory alterations;
- Uncorrected visual and/or auditory alterations;
- Cognitive impairment, detectable through the Telephone Montreal Cognitive Assessment (T-MoCA, \< 12);
- Inability to perform motor imageryT during the administration of the Kinesthetic and Visual Imagery Questionnaire - 20 (KVIQ-20, \< 20)
The study team makes the final eligibility decision.
Where it's taking place
- São Paulo, São Paulo, Brazil
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The study runs about 6 weeks per participant, based on its public description. The team confirms the exact schedule and number of visits before you enroll.
Who can join this trial?
This study is enrolling all sexes, not specified. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include São Paulo, São Paulo, Brazil. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.